-
<![CDATA[Top 10 Urology Times prostate cancer articles of 2025]]>
22 Dec 2025 14:35 GMT
… with prostate cancer who have suspected metastases and … metastatic castration-resistant prostate cancer unselected for homologous … with metastatic castration-resistant prostate cancer, Johnson & … -prostate-cancer/
4. FDA approves new prostate cancer …
-
Can men hold off on treating recurring prostate cancer?
19 Dec 2025 18:47 GMT
… PSA without ever developing metastases.
Now, an ultra- … or mortality from their prostate cancer,” Dr. Einstein and … “natural history” of prostate cancers that reappear and are … other causes before recurring prostate cancer needs treatment. Pre-existing …
-
Markey study finds key pathway in prostate cancer bone metastatic progression
19 Dec 2025 15:37 GMT
… for patients with bone metastases, which occur in … metastatic prostate cancer.
By Elizabeth Chapin, UKnow
When prostate cancer spreads … patients with advanced prostate cancer, the researchers detected … key pathway in prostate cancer bone metastatic progression …
-
Markey study identifies pathway driving prostate cancer bone metastatic progression
19 Dec 2025 14:58 GMT
… Center study reveals how prostate cancer cells adapt their … for patients with bone metastases, which occur in … die from metastatic prostate cancer.
When prostate cancer spreads to the … from patients with advanced prostate cancer, the researchers detected …
-
FDA grants regular approval to rucaparib for metastatic castration-resistant prostate cancer
18 Dec 2025 00:29 GMT
… somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) previously treated with an … performance status, presence of hepatic metastases, and type of mutation (BRCA1m …
-
Top Cancer Stories of 2025
22 Dec 2025 06:21 GMT
… dormant cancer cells and increased metastasis. They observed that these reawakened … a viable strategy to slow prostate cancer. By treating mice with the … team found that MSB promotes prostate cancer cell death by targeting a …
-
Telix provides updates on precision medicine pipeline
22 Dec 2025 05:29 GMT
… 68Ga-PSMA-11) for prostate cancer imaging in Chinese patients. … recurrence (BCR) of prostate cancer following prior radical prostatectomy … lymph nodes, and organ metastases (non-bone); 94.7% … men were diagnosed with prostate cancer in 2022[4], increasing …
-
Illuccix China Phase 3 study supports Telix Pharmaceuticals'...
22 Dec 2025 00:48 GMT
… with biochemical recurrence of prostate cancer following surgery or radiation … , lymph node and organ metastases, while PPV was 94. … and 87.0% in bone metastases. Imaging results also influenced … 000 men were diagnosed with prostate cancer in 2022, with case …
-
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
21 Dec 2025 21:38 GMT
… 68Ga-PSMA-11) for prostate cancer imaging in Chinese patients. … recurrence (BCR) of prostate cancer following prior radical prostatectomy … lymph nodes, and organ metastases (non-bone); 94.7% … men were diagnosed with prostate cancer in 20224, increasing by …
-
A beloved wrestling coach gets surprise from a Secret Santa as he’s walking into cancer treatment
20 Dec 2025 15:09 GMT
… , James was diagnosed with prostate cancer. The disease quickly metastasized to his spine …